The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

Dupilumab specifically binds to IL-4 receptor alpha, which leads to decreased signaling of IL-4 and IL-13, which then results in decreased type two inflammation. Biological therapies should be ...

The final appraisal document for Dupixent (dupilumab) has given the green light ... It is the second indication for the IL-4 and IL-13 inhibitor cleared for use by the NHS in England and Wales ...

Sanofi/Regeneron's IL-4 and IL-13 inhibitor Dupixent (dupilumab) was approved to treat CRSwNP in 2019, and was joined on the US market by GSK's IL-5 inhibitor Nucala (mepolizumab) last year.

The following is a summary of “Longitudinal integrated proteomic and metabolomic skin changes in atopic dermatitis patients ...

Fewer than 10% of children or adolescents with peanut allergy passed a desnsitiaztion food challenge after receiving dupilumab for 24 weeks. Image: Adobe Stock “The impact of the findings for ...

Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...

The Trump administration, DOJ sues Illinois and Chicago over some of its immigration laws. The lawsuit argues that the government has authority to regulate immigration, but it needs to work with ...

Trump administration officials are suing Illinois and top state officials, hoping to force them to turn over suspected illegal immigrants rather than releasing them from jails and state prisons.

President Trump’s Justice Department sued the state of Illinois, the city of Chicago and local officials Thursday over laws creating a sanctuary city. Accusing the officials of impeding federal ...

The Trump administration sued officials in Illinois, Chicago, and Cook County on Thursday over policies that limit cooperation with federal immigration enforcement authorities, accusing them of ...

We report a vesicular reaction close to patch-test sites that had been previously marked with an Edding 3000 permanent marker. A 42-year-old housewife and teacher came to our allergy department ...